Oracle Corp. Files 10-Q for Q2 2025
Ticker: ORCL-PD · Form: 10-Q · Filed: Dec 10, 2024 · CIK: 1341439
| Field | Detail |
|---|---|
| Company | Oracle CORP (ORCL-PD) |
| Form Type | 10-Q |
| Filed Date | Dec 10, 2024 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, earnings, financials, cloud
Related Tickers: AMPH
TL;DR
Oracle's Q2 10-Q is in, check cloud and license numbers.
AI Summary
Oracle Corp. filed its 10-Q for the period ending November 30, 2024, reporting on its fiscal second quarter. The filing details various financial aspects, including cloud services, license support, and hardware business segments. It also mentions specific financial instruments like convertible debt securities and equity components, with references to Safra Catz and Ampere Computing Holdings LLC.
Why It Matters
This filing provides investors with an update on Oracle's financial performance and operational segments, crucial for understanding the company's current health and future prospects in the competitive tech market.
Risk Assessment
Risk Level: medium — The filing covers a period of significant financial activity and strategic reporting, indicating a need for careful analysis of its contents.
Key Numbers
- 2024-11-30 — Fiscal Period End (Reporting period for the 10-Q filing.)
- 2023-11-30 — Prior Year Period End (Comparison point for financial performance.)
- 2024-06-01 — Start of Current Reporting Period (Beginning of the fiscal second quarter.)
Key Players & Entities
- ORACLE CORP (company) — Filer
- 20241130 (date) — Period of Report
- 0000950170-24-134973 (other) — Accession Number
- Safra Catz (person) — Mentioned executive
- Ampere Computing Holdings LLC (company) — Mentioned entity
- us-gaap:ConvertibleDebtSecuritiesMember (financial_instrument) — Financial reporting item
FAQ
What were the key financial highlights for Oracle Corp. in the period ending November 30, 2024?
The filing covers the period ending November 30, 2024, and includes details on segments like Cloud Services and License Support, and the Hardware Business.
Does the filing mention any specific restructuring activities?
Yes, the filing references 'Fiscal2024OracleRestructuringMember' for the periods June 1, 2024, to November 30, 2024, and June 1, 2023, to November 30, 2023.
Are there any mentions of convertible debt securities?
Yes, the filing includes 'us-gaap:ConvertibleDebtSecuritiesMember' with a date of March 5, 2024.
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20241130, indicating the period ending November 30, 2024.
Are there any specific geographical segments mentioned?
Yes, the filing references 'srt:AsiaPacificMember' for the period June 1, 2024, to November 30, 2024.
Filing Stats: 4,469 words · 18 min read · ~15 pages · Grade level 19.2 · Accepted 2024-12-10 16:11:21
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share 3.125% senior notes due Jul
Filing Documents
- orcl-20241130.htm (10-Q) — 3149KB
- orcl-ex31_01.htm (EX-31.01) — 19KB
- orcl-ex32_01.htm (EX-32.01) — 11KB
- 0000950170-24-134973.txt ( ) — 10280KB
- orcl-20241130.xsd (EX-101.SCH) — 1066KB
- orcl-20241130_htm.xml (XML) — 1998KB
Financial Statements (Unaudited)
Financial Statements (Unaudited) 3 Condensed Consolidated Balance Sheets as of November 30, 2024 and May 31, 2024 3 Condensed Consolidated Statements of Operations for the Three and Six Months Ended November 30, 2024 and 2023 4 Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months Ended November 30, 2024 and 2023 5 Condensed Consolidated Statements of Stockholders' Equity for the Three and Six Months Ended November 30, 2024 and 2023 6 Condensed Consolidated Statements of Cash Flows for the Six Months Ended November 30, 2024 and 2023 7 Notes to Condensed Consolidated Financial Statements 8 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 22 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 39 Item 4.
Controls and Procedures
Controls and Procedures 39 PART II. OTHER INFORMATION 40 Item 1.
Legal Proceedings
Legal Proceedings 40 Item 1A.
Risk Factors
Risk Factors 40 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 40 Item 5. Other Information 41 Item 6. Exhibits 42
Signatures
Signatures 44 Table of Contents Cautionary Note on Forward-Looking Statements For purposes of this Quarterly Report on Form 10-Q (this Quarterly Report), the terms "Oracle," "we," "us" and "our" refer to Oracle Corporation and its consolidated subsidiaries. This Quarterly Report contains statements that are not historical in nature, are predictive in nature, or that depend upon or refer to future events or conditions or otherwise contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), and Section 27A of the Securities Act of 1933, as amended (the Securities Act). These include, among other things, statements regarding: our expectation that we may acquire, and realize the anticipated benefits of acquiring, companies, products, services and technologies to further our corporate strategy as compelling opportunities become available; our expectation that, on a constant currency basis, our total cloud and license revenues generally will continue to increase due to expected growth in our cloud services and continued demand for our cloud license and on-premise license and license support offerings; our expectation that substantially all of our customers will renew their license support contracts upon expiration; our expectation that current and expected customer demand will require continued growth in our cloud services and license support expenses in order to increase our existing data center capacity and establish additional data centers in new geographic locations; our expectation that our hardware business will have lower operating margins as a percentage of revenues than our cloud and license business; our expectation that we will continue to make significant investments in research and development to maintain and improve our current products and service offerings, and our belief that research and development efforts are essential to maintaining our competitive posi
FINANCI AL INFORMATION
PART I. FINANCI AL INFORMATION
Financial St atements (Unaudited)
Item 1. Financial St atements (Unaudited) ORACLE CORPORATION CONDENSED CONSOLIDA TED BALANCE SHEETS As of November 30, 2024 and May 31, 2024 (Unaudited) (in millions, except per share data) November 30, 2024 May 31, 2024 ASSETS Current assets: Cash and cash equivalents $ 10,941 $ 10,454 Marketable securities 370 207 Trade receivables, net of allowances for credit losses of $ 546 and $ 485 as of November 30, 2024 and May 31, 2024, respectively 8,177 7,874 Prepaid expenses and other current assets 4,015 4,019 Total current assets 23,503 22,554 Non-current assets: Property, plant and equipment, net 26,432 21,536 Intangible assets, net 5,679 6,890 Goodwill, net 62,204 62,230 Deferred tax assets 11,984 12,273 Other non-current assets 18,681 15,493 Total non-current assets 124,980 118,422 Total assets $ 148,483 $ 140,976 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Notes payable and other borrowings, current $ 8,162 $ 10,605 Accounts payable 2,679 2,357 Accrued compensation and related benefits 1,653 1,916 Deferred revenues 9,430 9,313 Other current liabilities 7,128 7,353 Total current liabilities 29,052 31,544 Non-current liabilities: Notes payable and other borrowings, non-current 80,462 76,264 Income taxes payable 9,553 10,817 Deferred tax liabilities 2,864 3,692 Other non-current liabilities 12,316 9,420 Total non-current liabilities 105,195 100,193 Commitments and contingencies Oracle Corporation stockholders' equity: Preferred stock, $ 0.01 par value—authorized: 1.0 shares; outstanding: none — — Common stock, $ 0.01 par value and additional paid in capital—authorized: 11,000 shares; outstanding: 2,796 shares and 2,755 shares as of November 30, 2024 and May 31, 2024, respectively 34,310 32,764 Accumulated deficit ( 19,045 ) ( 22,628 ) Accumulated other